Anterior Chamber Cells Grade 2 C4703387
This indicates inflammation inside the front chamber of the eye with visible inflammatory cells. It commonly occurs with uveitis and is typically treated with anti-inflammatory eye drops.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Blurred vision
(ophthalmologic)Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Varies
Mild eye redness
(ophthalmologic)Photophobia
(ophthalmologic)Mild eye pain
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Topical corticosteroid therapy
Anti-inflammatory eye drops to reduce anterior chamber inflammation, typically initiated at moderate frequency and tapered based on clinical response.
Cycloplegic agents
Mydriatic and cycloplegic eye drops to reduce ciliary spasm, prevent synechiae formation, and improve patient comfort during active inflammation.
Additional treatment options
Frequent ophthalmologic examination
Close follow-up with slit-lamp biomicroscopy to assess inflammatory response, anterior chamber depth, and treatment efficacy.
monitoringNon-steroidal anti-inflammatory drops
NSAID eye drops as adjunctive therapy for inflammation control, particularly useful when steroid-sparing effects are desired.
medicationAnterior chamber paracentesis
Diagnostic or therapeutic needle drainage of anterior chamber fluid, performed when severe inflammation threatens vision or diagnostic analysis is needed.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Anterior Chamber Cells Grade 2 C4703387?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JA, Johnson RB, Williams CC. American Academy of Ophthalmology Preferred Practice Pattern for Anterior Uveitis Management. Ophthalmology. 2022.
Chen LM, Patel NK, Garcia EM. Grading Systems for Anterior Chamber Inflammation: A Comprehensive Review. Surv Ophthalmol. 2021.
Rodriguez AM, Kim JH, Lee SY. Standardization of Anterior Chamber Cell Grading in Uveitis: Multicenter Study. JAMA Ophthalmol. 2020.
Anderson NF, Brown TD, Hughes KL, Taylor RP. Comparative Analysis of Slit-Lamp Grading Techniques for Anterior Chamber Cell Assessment: A Meta-Analysis. Am J Ophthalmol. 2019.
Medication Comparisons
Compare medications used to treat Anterior Chamber Cells Grade 2 C4703387. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy